HighTower Advisors, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$808,000
-29.1%
25,579
-8.4%
0.00%0.0%
Q2 2023$1,139,000
+7.9%
27,939
-1.5%
0.00%0.0%
Q1 2023$1,056,000
+16.0%
28,366
+8.7%
0.00%0.0%
Q4 2022$910,000
-41.5%
26,087
-6.1%
0.00%
-50.0%
Q3 2022$1,555,000
+8.1%
27,795
+0.4%
0.00%0.0%
Q2 2022$1,438,000
-40.4%
27,683
-16.4%
0.00%
-20.0%
Q1 2022$2,411,000
-45.0%
33,112
-10.6%
0.01%
-50.0%
Q4 2021$4,384,000
+1.6%
37,057
+15.1%
0.01%
-16.7%
Q3 2021$4,317,000
-6.6%
32,184
+12.8%
0.01%
-7.7%
Q2 2021$4,622,000
+65.3%
28,524
-18.2%
0.01%
+44.4%
Q1 2021$2,796,000
+74.2%
34,856
+17.9%
0.01%
+28.6%
Q4 2020$1,605,000
+112.3%
29,552
-22.4%
0.01%
+75.0%
Q3 2020$756,000
+140.8%
38,104
+155.7%
0.00%
+100.0%
Q2 2020$314,000
+86.9%
14,900
+8.2%
0.00%
+100.0%
Q1 2020$168,000
-23.3%
13,775
-8.7%
0.00%0.0%
Q4 2019$219,000
-5.2%
15,083
-12.9%
0.00%0.0%
Q3 2019$231,000
-61.4%
17,325
-52.5%
0.00%
-75.0%
Q2 2019$598,000
+0.7%
36,437
+5.3%
0.00%0.0%
Q1 2019$594,000
+195.5%
34,611
+135.0%
0.00%
+100.0%
Q4 2018$201,000
-44.2%
14,726
+16.8%
0.00%
-33.3%
Q3 2018$360,000
+59.3%
12,611
+52.6%
0.00%
+50.0%
Q2 2018$226,000
-22.9%
8,266
-45.6%
0.00%0.0%
Q4 2017$293,00015,2000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders